Home › Alcohol Use Disorder (AUD) › NCT03845205

Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH

Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for Severe Alcoholic Hepatitis (SAH)

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* English speaking

Exclusion Criteria:

* too medically/psychiatrically ill to participate
* not able to provide informed consent due to cognitive impairment

About the study

Given the severe consequences of alcohol relapse following liver transplantation for alcoholic hepatitis (AH-LT), it is critical to accurately identify alcohol use and implement alcohol interventions early in the post-transplant period to optimize patient outcomes. The proposed randomized clinical trial will examine the implementation and effects of integrated, person- and computer-delivered alcohol treatment compared to standard care on alcohol use (assessed by self-report and biomarker), mood, quality of life and survival following AH-LT. Predictors of 12-month post-transplant alcohol outcomes will be explored to allow future improved tailoring and targeting of these treatments.

What is being tested

• Integrated AUD Treatment (behavioral)

Sponsor: Johns Hopkins University · Participants: 200 · Started: Nov 20, 2020

Contact the study team

• MARY E MCCAUL, PhD · Phone: 410-955-9526
• Victor Chen, MD · Phone: 410-550-1793

Official record on ClinicalTrials.gov — NCT03845205

Locations in the U.S.

Conditions

• Alcohol Use Disorder (AUD)
• Alcoholic Hepatitis

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.